Increased serum concentration of BAFF/APRIL and IgA2 subclass in patients with mixed connective tissue disease complicated by interstitial lung disease.
about
Serum B cell-activating factor (BAFF) level in connective tissue disease associated interstitial lung diseaseRapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells.IL-2, IL-4, IFN-γ or TNF-α enhances BAFF-stimulated cell viability and survival by activating Erk1/2 and S6K1 pathways in neoplastic B-lymphoid cells.Rapamycin inhibits BAFF-stimulated cell proliferation and survival by suppressing mTOR-mediated PP2A-Erk1/2 signaling pathway in normal and neoplastic B-lymphoid cells.
P2860
Increased serum concentration of BAFF/APRIL and IgA2 subclass in patients with mixed connective tissue disease complicated by interstitial lung disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Increased serum concentration ...... by interstitial lung disease.
@en
Increased serum concentration ...... by interstitial lung disease.
@nl
type
label
Increased serum concentration ...... by interstitial lung disease.
@en
Increased serum concentration ...... by interstitial lung disease.
@nl
prefLabel
Increased serum concentration ...... by interstitial lung disease.
@en
Increased serum concentration ...... by interstitial lung disease.
@nl
P2093
P2860
P1433
P1476
Increased serum concentration ...... by interstitial lung disease.
@en
P2093
Hirofumi Amano
Jun Suzuki
Kentaro Minowa
Seiichiro Ando
Shinji Morimoto
Shinya Kawano
Soichiro Nakano
Takashi Watanabe
Toshiyuki Kaneko
Yoshiaki Tokano
P2860
P304
P356
10.3109/14397595.2013.843748
P577
2013-11-07T00:00:00Z